Over the course of the forecast period, it is anticipated that the prevalence of chronic blood diseases, such as blood cancers like leukaemia, lymphoma, and myeloma, blood disorders like anaemia, and bleeding disorders like blood clots and haemophilia, will propel Elastomeric Infusion Pumps market expansion.
For instance, the Sickle Cell Disease (SCD) affects about 100,000 Americans annually, according to the Centers for Disease Control and Prevention (CDC) in 2019. Additionally, the Leukemia & Lymphoma Society predicted that in 2017, approximately 172,910 Americans were projected to get a diagnosis of leukaemia, lymphoma, or myeloma.
Read More:
https://knackersblogger.blogspot.com/2022/09/elastomeric-infusion-pumps-market-size.html
Click here for Elastomeric Infusion Pumps Market Press Release
